Ocugen (OCGN) Assets Average (2015 - 2026)
Ocugen (OCGN) posted Assets Average of $50.2 million for Q1 2026, down 0.68% on a QoQ basis from $50.6 million in Q4 2025, and down 31.64% year-over-year from $73.5 million in Q1 2025.
Ocugen (OCGN) Assets Average (2015 - 2026) Analysis & Trends
Ocugen's Assets Average history runs 12 years deep, the most recent figure standing at $50.2 million for Q1 2026.
- Quarterly Assets Average fell 31.64% year-over-year to $50.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.2 million (down 31.64% YoY) and the FY2025 annual result came in at $63.0 million, down 14.31% from the prior year.
- Assets Average was $50.2 million for Q1 2026 at Ocugen, down from $50.6 million in the prior quarter.
- Across five years, Assets Average topped out at $135.9 million in Q2 2022 and bottomed at $46.2 million in Q2 2024.
- A 5-year average of $79.9 million and a median of $72.2 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 204.7% — and 2024, when it slumped 50.16%.
- Ocugen's Assets Average stood at $112.4 million in 2022, then tumbled by 38.08% to $69.6 million in 2023, then rose by 3.69% to $72.2 million in 2024, then retreated by 29.97% to $50.6 million in 2025, then slipped by 0.68% to $50.2 million in 2026.
- Business Quant data shows OCGN's Assets Average at $50.2 million in Q1 2026, $50.6 million in Q4 2025, and $55.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 50.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.21 Mn |
| Dec 31, 2025 | 50.56 Mn |
| Sep 30, 2025 | 55.60 Mn |
| Jun 30, 2025 | 59.03 Mn |
| Mar 31, 2025 | 73.45 Mn |
| Dec 31, 2024 | 72.19 Mn |
| Sep 30, 2024 | 51.24 Mn |
| Jun 30, 2024 | 46.17 Mn |
| Mar 31, 2024 | 58.17 Mn |
| Dec 31, 2023 | 69.62 Mn |
| Sep 30, 2023 | 81.83 Mn |
| Jun 30, 2023 | 92.64 Mn |
| Mar 31, 2023 | 102.47 Mn |
| Dec 31, 2022 | 112.44 Mn |
| Sep 30, 2022 | 123.16 Mn |
| Jun 30, 2022 | 135.91 Mn |
| Mar 31, 2022 | 123.74 Mn |
| Dec 31, 2021 | 111.04 Mn |
| Sep 30, 2021 | 120.28 Mn |
| Jun 30, 2021 | 89.05 Mn |